[Federal Register Volume 62, Number 224 (Thursday, November 20, 1997)]
[Notices]
[Pages 62060-62061]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-30477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-98-04]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Wilma Johnson, CDC
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA
30333. Written comments should be received within 60 days of this
notice.
Proposed Projects
1. Defining Gulf War Illness; New
This study will characterize and compare alternative
classifications for symptoms and functional disability which remain
medically unexplained in Gulf War veterans. This will be accomplished
in three phases. Phase I will assess persistence and stability of
symptoms over time, as well as compare the performance of data-driven
case definitions derived from two samples: (1) the New Jersey Center
for Environmental Hazards Research
[[Page 62061]]
sample of Gulf War veterans participating in the Department of Veterans
Affairs Gulf War Registry; and (2) a cohort of Air Force members from a
previous CDC study of Gulf War veterans and Gulf War-era controls from
Pennsylvania and Florida. In addition to assessing data-driven case
definitions for illness among Gulf War veterans, existing definitions
for medically unexplained symptoms, such as chronic fatigue syndrome,
multiple chemical sensitivity, and fibromyalgia will be evaluated.
Phase II will attempt to assess the generalizability of both derived
and existing case definitions in a random sample of deployed and non-
deployed Gulf War era veterans. Phase III will consist of a
standardized telephone interview for the assessment of psychiatric
conditions. This will be administered to a sample of Phase I and Phase
II participants who are identified through their responses to paper-
and-pencil questionnaires as having high levels of psychologic
distress. There is no cost to respondents.
----------------------------------------------------------------------------------------------------------------
No. of Avg. Burden/
Respondents No. of Responses/ Response (in Total Burden
Respondents Respondent hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Administer questionnaire to the New Jersey
Center for Environmental Hazards Research
sample of the Department of Veterans Affairs
Gulf War Registry veterans and the previous CDC
Air Force Cohort (Phase)....................... 7,312 1 0.45 5,484
Administer questionnaire to new random sample of
Gulf War veterans and era controls (Phase II).. 3,000 1 .45 2,250
Telephone survey of Phase I and Phase II
participants who screened positive for
psychiatric conditions......................... 600 1 2 1,200
---------------------------------------------------------------
Total....................................... .............. .............. .............. 8,934
----------------------------------------------------------------------------------------------------------------
Dated: November 13, 1997.
Wilma G. Johnson,
Acting Associate Director for Policy Planning and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 97-30477 Filed 11-19-97; 8:45 am]
BILLING CODE 4163-18-P